The researchers showed that the AI-driven system not only detects well-known cancer genes but also uncovers previously hidden ones...
This release introduces hardware and software enhancements designed to improve workflow efficiency and system performance...
Robust clinical pipeline that spans multiple late-stage studies across intermediate- and high-risk NMIBC...
FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent prostate cancer...
Integrated with the OrthoPulse App and Doctor Portal 2.0, OrthoPulse lite forms a connected, data-driven ecosystem...
The Company will collaborate with DK Healthcare to obtain the necessary regulatory clearances ahead of commercial launch in South Korea...
Cerene is rapidly gaining traction among clinicians seeking predictable outcomes without the pain, scarring, or anaesthesia requirements associated with heat-based methods...
Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice...
The clinical study was conducted at the Territorial Medical Association of Yangiyul district, Republic of Uzbekistan, and received Ethics Committee approval...
Preat introduces its first proprietary overdenture attachment system to advance overdenture reliability through performance and partnership...
